腎移植循環器診療マニュアル

出版社： 東京医学社
著者：
発行日： 2015-03-31
分野： 臨床医学：内科  >  腎臓
ISBN： 9784885632501
電子書籍版： 2015-03-31 （第1版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,400 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,400 円(税込)

購入する

目次

  • 腎移植循環器診療マニュアル

    ―目次―

    1．生命予後と移植後心血管疾患
    2．手術リスク、心リスク、移植腎リスク
    3．冠動脈疾患の既往がないときの術前評価
    4．冠動脈疾患の既往があるが、
    　　心筋梗塞による心機能低下がないときの術前評価
    5．心筋梗塞による心機能低下があるときの術前評価
    6．冠血行再建術
    7．大動脈弁狭窄症
    8．その他の弁膜症
    9．左室収縮障害による低心機能と左室拡張障害
    10．糖尿病合併患者に対する術前評価
    11．先行的腎移植
    12．脳卒中
    13．末梢動脈疾患
    14．高齢者の腎移植
    15．術前の冠危険因子管理
    16．周術期管理
    17．冠危険因子と冠動脈疾患の移植後管理
    18．透析再導入時の注意点

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1. 生命予後と移植後心血管疾患

P.8 掲載の参考文献
1) Chapter 5 : Mortality, USRDS annual report 2014. Available from : http://www.usrds.org/2014/download/V2_Ch_05_Mortality_14.pdf.
 
2) 日本透析医学会. 透析人口における平均余命, わが国の慢性透析療法の現況 2005. Available from : http://docs.jsdt.or.jp/overview/pdf2006/p43.pdf.
 
3) Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure : evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 1998 ; 9 (11) : 2135-41.
PubMed
4) Ojo AO, Port FK, Wolfe RA, Mauger EA, Williams L, Berling DP. Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis 1994 ; 24 (1) : 59-64.
PubMed
5) Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999 ; 341 (23) : 1725-30.
PubMed
6) Rabbat CG, Thorpe KE, Russell JD, Churchill DN. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol 2000 ; 11 (5) : 917-22.
 
7) Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease : trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol 2001 ; 12 (6) : 1293-6.
PubMed
8) Oniscu GC, Brown H, Forsythe JL. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 2005 ; 16 (6) : 1859-65.
PubMed
9) Gill JS, Tonelli M, Johnson N, Kiberd B, Landsberg D, Pereira BJ. The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int 2005 ; 68 (5) : 2345-51.
PubMed
10) Pauly RP, Gill JS, Rose CL, Asad RA, Chery A, Pierratos A, et al. Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 2009 ; 24 (9) : 2915-9.
PubMed
11) Ojo A, Wolfe RA, Agodoa LY, Held PJ, Port FK, Leavey SF, et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation : multivariate analyses from the United States Renal Data System. Transplantation 1998 ; 66 (12) : 1651-9.
PubMed
12) Rao PS, Schaubel DE, Wei G, Fenton SS. Evaluating the survival benefit of kidney retransplantation. Transplantation 2006 ; 82 (5) : 669-74.
PubMed
13) Cueto-Manzano AM, Morales-Buenrostro LE, Gonzalez-Espinoza L, Gonzalez-Tableros N, Martin-del-Campo F, Correa-Rotter R, et al. Markers of inflammation before and after renal transplantation. Transplantation 2005 ; 80 (1) : 47-51.
 
14) Ducloux D, Kazory A, Chalopin JM. Predicting coronary heart disease in renal transplant recipients : a prospective study. Kidney Int 2004 ; 66 (1) : 441-7.
PubMed
15) Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, et al. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 1994 ; 343 (8912) : 1519-22.
PubMed
16) Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation : the challenge of diabetes. Am J Transplant 2008 ; 8 (3) : 593-9.
PubMed
17) Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol : JASN 2005 ; 16 (2) : 496-506.
PubMed
18) Lentine KL, Schnitzler MA, Abbott KC, Li L, Burroughs TE, Irish W, et al. De novo congestive heart failure after kidney transplantation : a common condition with poor prognostic implications. Am J Kidney Dis 2005 ; 46 (4) : 720-33.
PubMed
19) Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 2004 ; 4 (10) : 1662-8.
PubMed
20) 日本透析医学会. わが国の慢性透析療法の現況 2013. Available from : http://docs.jsdt.or.jp/overview/pdf2014/p022.pdf.
 
21) 日本移植学会. 臓器移植ファクトブック 2014. Available from : http://www.asas.or.jp/jst/pdf/factbook/factbook2014.pdf.
 
22) Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States : the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003 ; 14 (12) : 3270-7.
PubMed
23) 井関邦敏. 現状と問題点-世界の透析の現状と問題点. 腎と透析 2014 ; 76 (増刊【透析・腎移植のすべて】) : 45-8.
 
24) Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease : a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003 ; 108 (17) : 2154-69.
PubMed
25) Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol : JASN 2002 ; 13 (3) : 745-53.
PubMed
26) Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts : a collaborative meta-analysis. Lancet 2010 ; 375 (9731) : 2073-81.
PubMed
27) Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 ; 351 (13) : 1296-305.
PubMed
28) Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes : a meta-analysis. Lancet 2012 ; 380 (9854) : 1662-73.
PubMed
29) Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension : a meta-analysis. Lancet 2012 ; 380 (9854) : 1649-61.
PubMed
30) Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004 ; 44 (2) : 198-206.
PubMed
31) Henrich WL. Principles and practice of dialysis. Baltimore : Williams & Wilkins, 1994 : xiv, 478.
 
32) Rashidi A, Sehgal AR, Rahman M, O'Connor AS. The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years. Am J Cardiol 2008 ; 102 (12) : 1668-73.
 
33) Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006 ; 3 (11) : e442.
PubMed
34) Patel RK, Mark PB, Johnston N, McGregor E, Dargie HJ, Jardine AG. Renal transplantation is not associated with regression of left ventricular hypertrophy : a magnetic resonance study. Clin J Am Soc Nephrol 2008 ; 3 (6) : 1807-11.
 
35) Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, et al. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis 2014 ; 63 (1 Suppl) : A7.
 
36) Kasiske BL, Maclean JR, Snyder JJ. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol 2006 ; 17 (3) : 900-7.
PubMed
37) Ueshima H. Explanation for the Japanese paradox : prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb 2007 ; 14 (6) : 278-86.
PubMed
38) Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, et al. Cardiovascular disease and risk factors in Asia : a selected review. Circulation 2008 ; 118 (25) : 2702-9.
 
39) Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007 ; 297 (17) : 1892-900.
PubMed
40) Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, et al. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan : prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J 2013 ; 77 (4) : 934-43.
PubMed
41) Iwasaki M, Joki N, Tanaka Y, Hayashi T, Kubo S, Asakawa T, et al. Declining prevalence of coronary artery disease in incident dialysis patients over the past two decades. J Atheroscler Thromb 2014 ; 21 (6) : 593-604.
PubMed
42) De Vriese AS, De Bacquer DA, Verbeke FH, De Winter O, Franken PR, De Sutter JH, et al. Comparison of the prognostic value of dipyridamole and dobutamine myocardial perfusion scintigraphy in hemodialysis patients. Kidney Int 2009 ; 76 (4) : 428-36.
PubMed
43) De Vriese AS, Vandecasteele SJ, Van den Bergh B, De Geeter FW. Should we screen for coronary artery disease in asymptomatic chronic dialysis patients? Kidney Int 2012 ; 81 (2) : 143-51.
PubMed
44) Yasuda K, Kasuga H, Aoyama T, Takahashi H, Toriyama T, Kawade Y, et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol 2006 ; 17 (8) : 2322-32.
PubMed
45) Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans : what is the warranty period of a normal scan? J Am Coll Cardiol 2003 ; 41 (8) : 1329-40.
PubMed
46) Jones DG, Taylor AM, Enkiri SA, Lobo P, Brayman KL, Keeley EC, et al. Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation. Am J Transplant 2009 ; 9 (8) : 1846-52.
PubMed
47) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009 ; 9 Suppl 3 : S1-155.
 
48) Pilmore H. Cardiac assessment for renal transplantation. Am J Transplant 2006 ; 6 (4) : 659-65.
PubMed
49) Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988 ; 84 (6) : 985-92.
PubMed
50) Gill JS, Ma I, Landsberg D, Johnson N, Levin A. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol 2005 ; 16 (3) : 808-16.
PubMed
51) USRDS annual report 2013. Available from : http://www.usrds.org/2013/pdf/v2_ch7_13.pdf.
 
52) Braun WE. Long-term complications of renal transplantation. Kidney Int 1990 ; 37 (5) : 1363-78.
PubMed
53) USRDS. Chapter 6 : Transplantation, USRDS annual report 2014. Available from : http://www.usrds.org/2014/download/V2_Ch_06_Transplantation_14.pdf.
 
54) 日本移植学会・日本臨床腎移植学会. 腎移植臨床登録集計報告 (2014) -2013年実施症例の集計報告と追跡調査結果. 移植 2014 ; 49 (2-3) : 240-60.
 

2. 手術リスク, 心リスク, 移植腎リスク

P.18 掲載の参考文献
1) Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009 ; 30 (22) : 2769-812.
PubMed
2) Boersma E, Kertai MD, Schouten O, Bax JJ, Noordzij P, Steyerberg EW, et al. Perioperative cardiovascular mortality in noncardiac surgery : validation of the Lee cardiac risk index. Am J Med 2005 ; 118 (10) : 1134-41.
 
3) Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) : developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007 ; 116 (17) : e418-99.
 
4) Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class : advantages of a new specific activity scale. Circulation 1981 ; 64 (6) : 1227-34.
PubMed
5) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987 ; 316 (23) : 1429-35.
 
6) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991 ; 325 (5) : 293-302.
 
7) Ferreira SR, Moises VA, Tavares A, Pacheco-Silva A. Cardiovascular effects of successful renal transplantation : a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation 2002 ; 74 (11) : 1580-7.
PubMed
8) Rigatto C, Foley RN, Kent GM, Guttmann R, Parfrey PS. Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 2000 ; 70 (4) : 570-5.
PubMed
9) De Lima JJ, Vieira ML, Viviani LF, Medeiros CJ, Ianhez LE, Kopel L, et al. Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant 2002 ; 17 (4) : 645-51.
PubMed
10) Burt RK, Gupta-Burt S, Suki WN, Barcenas CG, Ferguson JJ, Van Buren CT. Reversal of left ventricular dysfunction after renal transplantation. Ann Intern Med 1989 ; 111 (8) : 635-40.
PubMed
11) Melchor JL, Espinoza R, Gracida C. Kidney transplantation in patients with ventricular ejection fraction less than 50 percent : features and posttransplant outcome. Transplant Proc 2002 ; 34 (7) : 2539-40.
PubMed
12) Wali RK, Wang GS, Gottlieb SS, Bellumkonda L, Hansalia R, Ramos E, et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 2005 ; 45 (7) : 1051-60.
PubMed
13) Zolty R, Hynes PJ, Vittorio TJ. Severe left ventricular systolic dysfunction may reverse with renal transplantation : uremic cardiomyopathy and cardiorenal syndrome. Am J Transplant 2008 ; 8 (11) : 2219-24.
PubMed
14) London GM, Pannier B, Marchais SJ, Guerin AP. Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol 2000 ; 11 (4) : 778-83.
 
15) Lucke JC, Samy RN, Atkins BZ, Silvestry SC, Douglas JM, Jr., Schwab SJ, et al. Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thorac Surg 1997 ; 64 (1) : 129-32 ; discussion 32-3.
PubMed
16) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med 1992 ; 327 (10) : 685-91.
PubMed
17) Postorino M, Marino C, Tripepi G, Zoccali C. Prognostic value of the New York Heart Association classification in end-stage renal disease. Nephrol Dial Transplant 2007 ; 22 (5) : 1377-82.
PubMed
18) Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans : what is the warranty period of a normal scan? J Am Coll Cardiol 2003 ; 41 (8) : 1329-40.
PubMed
19) Jones DG, Taylor AM, Enkiri SA, Lobo P, Brayman KL, Keeley EC, et al. Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation. Am J Transplant 2009 ; 9 (8) : 1846-52.
PubMed
20) State-specific mortality from sudden cardiac death : United States, 1999. MMWR Morb Mortal Wkly Rep 2002 ; 51 (6) : 123-6.
PubMed
21) Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001 ; 104 (18) : 2158-63.
PubMed
22) Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J 1998 ; 136 (2) : 205-12.
PubMed
23) Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 1992 ; 85 (1 Suppl) : I50-6.
 
24) Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) : developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008 ; 117 (21) : e350-408.
 
25) Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary : A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006 ; 27 (17) : 2099-140.
 
26) Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C, et al. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 2006 ; 3 (10) : 1196-201.
PubMed
27) Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999 ; 341 (8) : 577-85.
PubMed
28) Bock JS, Gottlieb SS. Cardiorenal syndrome : new perspectives. Circulation 2010 ; 121 (23) : 2592-600.
PubMed
29) Shamseddin MK, Parfrey PS. Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol 2009 ; 5 (11) : 641-9.
PubMed
30) Sarraf M, Masoumi A, Schrier RW. Cardiorenal syndrome in acute decompensated heart failure. Clin J Am Soc Nephrol 2009 ; 4 (12) : 2013-26.
PubMed
31) Liang KV, Williams AW, Greene EL, Redfield MM. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 2008 ; 36 (1 Suppl) : S75-88.
 
32) Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008 ; 52 (19) : 1527-39.
 

3. 冠動脈疾患の既往がないときの術前評価

P.25 掲載の参考文献
1) Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation 2005 ; 80 (6) : 815-20.
PubMed
2) Bunnapradist S, Danovitch GM. Evaluation of adult kidney transplant candidates. Am J Kidney Dis 2007 ; 50 (5) : 890-8.
PubMed
3) Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation : a meta-analysis. J Am Soc Nephrol : JASN 2003 ; 14 (2) : 431-9.
PubMed
4) Abbud-Filho M, Adams PL, Alberu J, Cardella C, Chapman J, Cochat P, et al. A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation 2007 ; 83 (8 Suppl) : S1-22.
 
5) Pilmore H. Cardiac assessment for renal transplantation. Am J Transplant 2006 ; 6 (4) : 659-65.
PubMed
6) Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 1991 ; 90 (5) : 563-70.
 
7) Wang LW, Fahim MA, Hayen A, Mitchell RL, Baines L, Lord S, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev 2011 (12) : CD008691.
PubMed
8) Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999 ; 130 (9) : 719-28.
PubMed
9) Khan MN, Pothier CE, Lauer MS. Chronotropic incompetence as a predictor of death among patients with normal electrograms taking beta blockers (metoprolol or atenolol). Am J Cardiol 2005 ; 96 (9) : 1328-33.
PubMed
10) McClellan JR, Travin MI, Herman SD, Baron JI, Golub RJ, Gallagher JJ, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997 ; 79 (5) : 600-5.
PubMed
11) Yao SS, Rozanski A. Principal uses of myocardial perfusion scintigraphy in the management of patients with known or suspected coronary artery disease. Prog Cardiovasc Dis 2001 ; 43 (4) : 281-302.
PubMed
12) Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death : differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998 ; 97 (6) : 535-43.
PubMed
13) Vanzetto G, Ormezzano O, Fagret D, Comet M, Denis B, Machecourt J. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients : study in 1137 patients with 6-year follow-up. Circulation 1999 ; 100 (14) : 1521-7.
PubMed
14) Gill JB, Ruddy TD, Newell JB, Finkelstein DM, Strauss HW, Boucher CA. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987 ; 317 (24) : 1486-9.
 
15) Nishimura S, Mahmarian JJ, Verani MS. Significance of increased lung thallium uptake during adenosine thallium-201 scintigraphy. J Nucl Med 1992 ; 33 (9) : 1600-7.
PubMed
16) De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003 ; 42 (3) : 263-8.
PubMed
17) Kasiske BL, Israni AK, Snyder JJ, Camarena A. Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST). Am J Kidney Dis 2011 ; 57 (6) : 908-16.
PubMed
18) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005 ; 45 (4 Suppl 3) : S1-153.
 
P.28 掲載の参考文献
1) Moroi M, et al. Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia. Int J Cardiol 2012 ; 158 (2) : 246?52.
 
2) http://www.ischemiatrial.org
 

4. 冠動脈疾患の既往があるが, 心筋梗塞による心機能低下がないときの術前評価

P.31 掲載の参考文献
1) Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans : what is the warranty period of a normal scan? J Am Coll Cardiol 2003 ; 41 (8) : 1329-40.
PubMed
2) Jones DG, Taylor AM, Enkiri SA, Lobo P, Brayman KL, Keeley EC, et al. Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation. Am J Transplant 2009 ; 9 (8) : 1846-52.
PubMed
3) Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation 2005 ; 80 (6) : 815-20.
PubMed
4) Bunnapradist S, Danovitch GM. Evaluation of adult kidney transplant candidates. Am J Kidney Dis 2007 ; 50 (5) : 890-8.
PubMed
5) Gaston RS, Danovitch GM, Adams PL, Wynn JJ, Merion RM, Deierhoi MH, et al. The report of a national conference on the wait list for kidney transplantation. Am J Transplant 2003 ; 3 (7) : 775-85.
PubMed
6) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005 ; 45 (4 Suppl 3) : S1-153.
 

5. 心筋梗塞による心機能低下があるときの術前評価

P.37 掲載の参考文献
1) Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ 2005 ; 173 (10) : 1181-4.
PubMed
2) Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009 ; 119 (14) : e391-479.
 
3) Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans : what is the warranty period of a normal scan? J Am Coll Cardiol 2003 ; 41 (8) : 1329-40.
PubMed
4) Jones DG, Taylor AM, Enkiri SA, Lobo P, Brayman KL, Keeley EC, et al. Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation. Am J Transplant 2009 ; 9 (8) : 1846-52.
PubMed

6. 冠血行再建術

P.43 掲載の参考文献
1) Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008 ; 72 (1) : 56-60.
PubMed
2) Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol 2006 ; 18 (12) : 577-83.
PubMed
3) Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int 1999 ; 56 (1) : 324-32.
PubMed
4) Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995 ; 25 (2) : 281-90.
PubMed
5) Reusser LM, Osborn LA, White HJ, Sexson R, Crawford MH. Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol 1994 ; 73 (13) : 965-7.
PubMed
6) Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA. Survival after coronary revascularization among patients with kidney disease. Circulation 2004 ; 110 (14) : 1890-5.
PubMed
7) Chang TI, Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA, Winkelmayer WC. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol 2012 ; 23 (12) : 2042-9.
PubMed
8) Szczech LA, Reddan DN, Owen WF, Califf R, Racz M, Jones RH, et al. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int 2001 ; 60 (1) : 292-9.
PubMed
9) Shroff GR, Solid CA, Herzog CA. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation 2013 ; 127 (18) : 1861-9.
PubMed
10) Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003 ; 107 (23) : 2900-7.
PubMed
11) Tarakji KG, Brunken R, McCarthy PM, Al-Chekakie MO, Abdel-Latif A, Pothier CE, et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation 2006 ; 113 (2) : 230-7.
PubMed
12) Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival : overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994 ; 344 (8922) : 563-70.
PubMed
13) Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983 ; 68 (4) : 785-95.
PubMed
14) O'Connor CM, Velazquez EJ, Gardner LH, Smith PK, Newman MF, Landolfo KP, et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol 2002 ; 90 (2) : 101-7.
 
15) Stigant C, Izadnegahdar M, Levin A, Buller CE, Humphries KH. Outcomes after percutaneous coronary interventions in patients with CKD : improved outcome in the stenting era. Am J Kidney Dis 2005 ; 45 (6) : 1002-9.
PubMed
16) Goy JJ, Kaufmann U, Goy-Eggenberger D, Garachemani A, Hurni M, Carrel T, et al. A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis : the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc 2000 ; 75 (11) : 1116-23.
PubMed
17) Goy JJ, Kaufmann U, Hurni M, Cook S, Versaci F, Ruchat P, et al. 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial. J Am Coll Cardiol 2008 ; 52 (10) : 815-7.
 
18) Sawhney N, Moses JW, Leon MB, Kuntz RE, Popma JJ, Bachinsky W, et al. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation 2004 ; 110 (4) : 374-9.
PubMed
19) Dangas G, Ellis SG, Shlofmitz R, Katz S, Fish D, Martin S, et al. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. J Am Coll Cardiol 2005 ; 45 (8) : 1186-92.
PubMed
20) Seung KB, Kim YH, Park DW, Lee BK, Lee CW, Hong MK, et al. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance. J Am Coll Cardiol 2005 ; 46 (5) : 787-92.
PubMed
21) McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention : incidence, risk factors, and relationship to mortality. Am J Med 1997 ; 103 (5) : 368-75.
PubMed
22) Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003 ; 15 (1) : 18-22.
PubMed
23) Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina : summary article : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Sta ble Angina). Circulation 2003 ; 107 (1) : 149-58.
 
24) Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004 ; 110 (14) : e340-437.
 
25) Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006 ; 47 (1) : e1-121.
 
26) Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005 ; 26 (8) : 804-47.
 
27) Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Eur Heart J 2010 ; 31 (20) : 2501-55.
PubMed
28) Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001 ; 344 (15) : 1117-24.
PubMed
29) Bhatt DL, Topol EJ. Debate : PCI or CABG for multivessel disease? Viewpoint : No clear winner in an unfair fight. Curr Controll Trials Cardiovasc Med 2001 ; 2 (6) : 260-2.
PubMed
30) Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005 ; 352 (21) : 2174-83.
PubMed
31) Aoki J, Ong AT, Arampatzis CA, Vijaykumar M, Rodriguez Granillo GA, Disco CM, et al. Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial). Am J Cardiol 2004 ; 94 (5) : 627-31.
PubMed
32) Kukreja N, Serruys PW, De Bruyne B, Colombo A, Macaya C, Richardt G, et al. Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery : analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II). Heart 2009 ; 95 (13) : 1061-6.
PubMed
33) Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994 ; 331 (8) : 496-501.
 
34) Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994 ; 331 (8) : 489-95.
 
35) Cutlip DE, Chauhan MS, Baim DS, Ho KK, Popma JJ, Carrozza JP, et al. Clinical restenosis after coronary stenting : perspectives from multicenter clinical trials. J Am Coll Cardiol 2002 ; 40 (12) : 2082-9.
PubMed
36) Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, et al. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. J Am Coll Cardiol 2009 ; 53 (17) : 1488-97.
 
37) Ellis SG, Stone GW, Cox DA, Hermiller J, O'Shaughnessy C, Mann T, et al. Long-term safety and efficacy with paclitaxel-eluting stents : 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR : Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent). JACC Cardiovascul Intervent 2009 ; 2 (12) : 1248-59.
 
38) Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation : five-year outcome of the j-Cypher Registry. Circulation 2012 ; 125 (4) : 584-91.
 
39) Sarno G, Lagerqvist B, Frobert O, Nilsson J, Olivecrona G, Omerovic E, et al. Lower risk of stent thrombosis and restenosis with unrestricted use o'f new-generation'drug-eluting stents : a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 2012 ; 33 (5) : 606-13.
 
40) Rabbitts JA, Nuttall GA, Brown MJ, Hanson AC, Oliver WC, Holmes DR, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008 ; 109 (4) : 596-604.
PubMed
41) Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003 ; 42 (2) : 234-40.
PubMed
42) Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 2005 ; 95 (6) : 755-7.
PubMed
43) Breen P, Lee JW, Pomposelli F, Park KW. Timing of high-risk vascular surgery following coronary artery bypass surgery : a 10-year experience from an academic medical centre. Anaesthesia 2004 ; 59 (5) : 422-7.
PubMed
P.47 掲載の参考文献
1) Tonino PAL, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009 ; 360 (3) : 213-24
 
2) De Bruyne B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012 ; 367 (11) : 991-1001
 

7. 大動脈弁狭窄症

P.52 掲載の参考文献
1) Forman MB, Virmani R, Robertson RM, Stone WJ. Mitral anular calcification in chronic renal failure. Chest 1984 ; 85 (3) : 367-71.
PubMed
2) Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 1992 ; 67 (3) : 236-9.
PubMed
3) London GM, Pannier B, Marchais SJ, Guerin AP. Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol 2000 ; 11 (4) : 778-83.
 
4) Stinebaugh J, Lavie CJ, Milani RV, Cassidy MM, Figueroa JE. Doppler echocardiographic assessment of valvular heart disease in patients requiring hemodialysis for end-stage renal disease. South Med J 1995 ; 88 (1) : 65-71.
PubMed
5) Nestico PF, Depace NL, Morganroth J, Kotler MN, Ross J. Mitral annular calcification : clinical, pathophysiology, and echocardiographic review. Am Heart J 1984 ; 107 (5 Pt 1) : 989-96.
 
6) Rubel JR, Milford EL. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population. Am J Kidney Dis 2003 ; 41 (2) : 411-21.
PubMed
7) Kajbaf S, Veinot JP, Ha A, Zimmerman D. Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am J Kidney Dis 2005 ; 46 (1) : 86-93.
PubMed
8) Salusky IB, Goodman WG. Cardiovascular calcification in end-stage renal disease. Nephrol Dial Transplant 2002 ; 17 (2) : 336-9.
PubMed
9) Floege J. When man turns to stone : extraosseous calcification in uremic patients. Kidney Int 2004 ; 65 (6) : 2447-62.
PubMed
10) Chizner MA, Pearle DL, deLeon AC Jr. The natural history of aortic stenosis in adults. Am Heart J 1980 ; 99 (4) : 419-24.
PubMed
11) Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968 ; 38 (1 Suppl) : 61-7.
 
12) Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation 1982 ; 66 (5) : 1105-10.
PubMed
13) Kitai T, Honda S, Okada Y, Tani T, Kim K, Kaji S, et al. Clinical outcomes in non-surgically managed patients with very severe versus severe aortic stenosis. Heart 2011 ; 97 (24) : 2029-32.
PubMed
14) Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010 ; 363 (17) : 1597-607.
PubMed
15) Ben-Dor I, Pichard AD, Gonzalez MA, Weissman G, Li Y, Goldstein SA, et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation 2010 ; 122 (11 Suppl) : S37-42.
PubMed
16) Maher ER, Pazianas M, Curtis JR. Calcific aortic stenosis : a complication of chronic uraemia. Nephron 1987 ; 47 (2) : 119-22.
PubMed
17) Urena P, Malergue MC, Goldfarb B, Prieur P, Guedon-Rapoud C, Petrover M. Evolutive aortic stenosis in hemodialysis patients : analysis of risk factors. Nephrologie 1999 ; 20 (4) : 217-25.
PubMed
18) Michel PL. Aortic stenosis in chronic renal failure patients treated by dialysis. Nephrol Dial Transplant 1998 ; 13 Suppl 4 : 44-8.
 
19) Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) : endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008 ; 118 (15) : e523-661.
 
20) Lucke JC, Samy RN, Atkins BZ, Silvestry SC, Douglas JM Jr, Schwab SJ, et al. Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thorac Surg 1997 ; 64 (1) : 129-32 ; discussion 132-3.
 
21) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005 ; 45 (4 Suppl 3) : S1-153.
 
P.54 掲載の参考文献
1) Leon MB, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010 ; 363 (17) : 1597-607.
PubMed
2) Smith CR, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011 ; 364 (23) : 2187?98.
 

8. その他の弁膜症

P.59 掲載の参考文献
1) Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J 1991 ; 12 Suppl B : 55-60.
 
2) Wood P. An appreciation of mitral stenosis. I. Clinical features. Br Med J 1954 ; 1 (4870) : 1051-63 ; contd.
PubMed
3) Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) : endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008 ; 118 (15) : e523-661.
 
4) Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 1992 ; 67 (3) : 236-9.
PubMed
5) D'Cruz IA, Madu EC. Progression to calcific mitral stenosis in end-stage renal disease. Am J Kidney Dis 1995 ; 26 (6) : 956-9.
PubMed
6) Forman MB, Virmani R, Robertson RM, Stone WJ. Mitral anular calcification in chronic renal failure. Chest 1984 ; 85 (3) : 367-71.
PubMed
7) Nestico PF, Depace NL, Morganroth J, Kotler MN, Ross J. Mitral annular calcification : clinical, pathophysiology, and echocardiographic review. Am Heart J 1984 ; 107 (5 Pt 1) : 989-96.
 
8) Rubel JR, Milford EL. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population. Am J Kidney Dis 2003 ; 41 (2) : 411-21.
PubMed
9) Kajbaf S, Veinot JP, Ha A, Zimmerman D. Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am J Kidney Dis 2005 ; 46 (1) : 86-93.
PubMed
10) Floege J. When man turns to stone : extraosseous calcification in uremic patients. Kidney Int 2004 ; 65 (6) : 2447-62.
PubMed
11) Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J 1962 ; 24 : 349-57.
PubMed
12) Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease. Natural history and results of surgery. Br Heart J 1975 ; 37 (1) : 74-8.
PubMed
13) Rowe JC, Bland EF, Sprague HB, White PD. The course of mitral stenosis without surgery : ten- and twenty-year perspectives. Ann Intern Med 1960 ; 52 : 741-9.
PubMed
14) Abernathy WS, Willis PW III. Thromboembolic complications of rheumatic heart disease. Cardiovasc Clin 1973 ; 5 (2) : 131-75.
 
15) Dahl JC, Winchell P, Borden CW. Mitral stenosis : a long term postoperative follow-up. Arch Intern Med 1967 ; 119 (1) : 92-7.
PubMed
16) Roy SB, Gopinath N. Mitral stenosis. Circulation 1968 ; 38 (1 Suppl) : 68-76.
 
17) Stinebaugh J, Lavie CJ, Milani RV, Cassidy MM, Figueroa JE. Doppler echocardiographic assessment of valvular heart disease in patients requiring hemodialysis for end-stage renal disease. South Med J 1995 ; 88 (1) : 65-71.
PubMed
18) Lavie CJ, Hebert K, Cassidy M. Prevalence and severity of Doppler-detected valvular regurgitation and estimation of right-sided cardiac pressures in patients with normal two-dimensional echocardiograms. Chest 1993 ; 103 (1) : 226-31.
PubMed
19) De Rossi SS, Glick M. Dental considerations for the patient with renal disease receiving hemodialysis. J Am Dent Assoc 1996 ; 127 (2) : 211-9.
PubMed
20) Duran CG, Pomar JL, Revuelta JM, Gallo I, Poveda J, Ochoteco A, et al. Conservative operation for mitral insufficiency : critical analysis supported by postoperative hemodynamic studies of 72 patients. J Thorac Cardiovasc Surg 1980 ; 79 (3) : 326-37.
PubMed
21) Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation : a multivariate analysis. Circulation 1995 ; 91 (4) : 1022-8.
PubMed
22) Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994 ; 90 (2) : 830-7.
PubMed
23) Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1994 ; 89 (1) : 191-7.
PubMed
24) Flemming MA, Oral H, Rothman ED, Briesmiester K, Petrusha JA, Starling MR. Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation. Am Heart J 2000 ; 140 (3) : 476-82.
PubMed
25) Zile MR, Gaasch WH, Carroll JD, Levine HJ. Chronic mitral regurgitation : predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress. J Am Coll Cardiol 1984 ; 3 (2 Pt 1) : 235-42.
 
26) Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, et al. Guidelines for the management of patients with valvular heart disease : executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998 ; 98 (18) : 1949-84.
 
27) Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, McGoon MD, Bailey KR, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation : results and clinical implications. J Am Coll Cardiol 1994 ; 24 (6) : 1536-43.
PubMed
28) Eguchi K, Ohtaki E, Matsumura T, Tanaka K, Tohbaru T, Iguchi N, et al. Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation. Eur Heart J 2005 ; 26 (18) : 1866-72.
PubMed
29) Grigioni F, Avierinos JF, Ling LH, Scott CG, Bailey KR, Tajik AJ, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation : determinants and long-term outcome. J Am Coll Cardiol 2002 ; 40 (1) : 84-92.
PubMed
30) Lim E, Barlow CW, Hosseinpour AR, Wisbey C, Wilson K, Pidgeon W, et al. Influence of atrial fibrillation on outcome following mitral valve repair. Circulation 2001 ; 104 (12 Suppl 1) : I59-63.
 
31) Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006 ; 48 (3) : e1-148.
 

9. 左室収縮障害による低心機能と左室拡張障害

P.70 掲載の参考文献
1) 日本循環器学会学術委員会. 慢性心不全治療ガイドライン2010年改訂版 (2013/9/13更新版). 2013.
 
2) He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women : NHANES I epidemiologic follow-up study. Arch Intern Med 2001 ; 161 (7) : 996-1002.
PubMed
3) Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994 ; 72 (2 Suppl) : S3-9.
 
4) Gheorghiade M, Bonow RO. Chronic heart failure in the United States : a manifestation of coronary artery disease. Circulation 1998 ; 97 (3) : 282-9.
PubMed
5) Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993 ; 87 (6 Suppl) : VI5-16.
 
6) de Mattos AM, Siedlecki A, Gaston RS, Perry GJ, Julian BA, Kew CE II, et al. Systolic dysfunction portends increased mortality among those waiting for renal transplant. J Am Soc Nephrol 2008 ; 19 (6) : 1191-6.
 
7) Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure : an epidemiologic perspective. J Am Coll Cardiol 1995 ; 26 (7) : 1565-74.
PubMed
8) Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction : prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999 ; 33 (7) : 1948-55.
 
9) Miyagishima K, Hiramitsu S, Kimura H, Mori K, Ueda T, Kato S, et al. Long term prognosis of chronic heart failure : reduced vs preserved left ventricular ejection fraction. Circ J 2009 ; 73 (1) : 92-9.
PubMed
10) Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Am J Cardiol 1984 ; 54 (7) : 778-82.
PubMed
11) Soufer R, Wohlgelernter D, Vita NA, Amuchestegui M, Sostman HD, Berger HJ, et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985 ; 55 (8) : 1032-6.
PubMed
12) Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community : a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998 ; 98 (21) : 2282-9.
PubMed
13) Francis GS. Development of arrhythmias in the patient with congestive heart failure : pathophysiology, prevalence and prognosis. Am J Cardiol 1986 ; 57 (3) : 3b-7b.
PubMed
14) Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001 ; 88 (5) : 530-3.
PubMed
15) Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure : Part I : diagnosis, prognosis, and measurements of diastolic function. Circulation 2002 ; 105 (11) : 1387-93.
PubMed
16) Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006 ; 355 (3) : 251-9.
PubMed
17) Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991 ; 83 (5) : 1676-84.
PubMed
18) Yamamoto K, Nishimura RA, Chaliki HP, Appleton CP, Holmes DR Jr, Redfield MM. Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease : critical role of left ventricular systolic function. J Am Coll Cardiol 1997 ; 30 (7) : 1819-26.
PubMed
19) Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure : a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007 ; 28 (20) : 2539-50.
 
20) 日本循環器学会. 慢性心不全治療ガイドライン2013/9/13更新版. Available from : http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf.
 
21) Patel RK, Mark PB, Johnston N, McGregor E, Dargie HJ, Jardine AG. Renal transplantation is not associated with regression of left ventricular hypertrophy : a magnetic resonance study. Clin J Am Soc Nephrol 2008 ; 3 (6) : 1807-11.
 
22) Moran A, Katz R, Jenny NS, Astor B, Bluemke DA, Lima JA, et al. Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C : the multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis 2008 ; 52 (5) : 839-48.
 
23) Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 2005 ; 67 (1) : 217-26.
PubMed
24) Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 2001 ; 12 (5) : 1079-84.
 
25) Foley RN, Curtis BM, Randell EW, Parfrey PS. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 2010 ; 5 (5) : 805-13.
PubMed
26) Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985 ; 312 (5) : 277-83.
PubMed
27) Vasan RS, Levy D. The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. Arch Intern Med 1996 ; 156 (16) : 1789-96.
PubMed
28) Fifer MA, Bourdillon PD, Lorell BH. Altered left ventricular diastolic properties during pacing-induced angina in patients with aortic stenosis. Circulation 1986 ; 74 (4) : 675-83.
PubMed
29) Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med 2004 ; 351 (11) : 1097-105.
PubMed
30) Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009 ; 119 (14) : e391-479.
 
31) Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure : executive summary : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013 ; 128 (16) : 1810-52.
 
32) Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994 ; 4 (7) : 1486-90.
 
33) Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996 ; 49 (5) : 1379-85.
PubMed
34) Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis 1996 ; 28 (1) : 53-61.
PubMed
35) Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P. Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients : a meta-analysis. Clin J Am Soc Nephrol 2009 ; 4 (4) : 755-62.
PubMed
36) Brenner BM, Rector FC. Brenner & Rector's the kidney, 8th ed. Philadelphia, Saunders Elsevier, 2008.
 
37) Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003 ; 115 (1) : 41-6.
PubMed
38) Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, et al. Cardiovascular mortality risk in chronic kidney disease : comparison of traditional and novel risk factors. JAMA 2005 ; 293 (14) : 1737-45.
PubMed
39) London GM, Fabiani F, Marchais SJ, de Vernejoul MC, Guerin AP, Safar ME, et al. Uremic cardiomyopathy : an inadequate left ventricular hypertrophy. Kidney Int 1987 ; 31 (4) : 973-80.
PubMed
40) Goto N, Tominaga Y, Matsuoka S, Sato T, Katayama A, Haba T, et al. Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients ; special focus on dilated cardiomyopathy. Clin Exp Nephrol 2005 ; 9 (2) : 138-41.
PubMed
41) Weisensee D, Low-Friedrich I, Riehle M, Bereiter-Hahn J, Schoeppe W. In vitro approach to 'uremic cardiomyopathy'. Nephron 1993 ; 65 (3) : 392-400.
PubMed
42) Aoki J, Ikari Y, Nakajima H, Mori M, Sugimoto T, Hatori M, et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 2005 ; 67 (1) : 333-40.
PubMed
43) Vanholder R, Glorieux G, Lameire N. Uraemic toxins and cardiovascular disease. Nephrol Dial Transplant 2003 ; 18 (3) : 463-6.
PubMed
44) Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease : a prospective study. Lancet 2001 ; 358 (9299) : 2113-7.
PubMed
45) Zolty R, Hynes PJ, Vittorio TJ. Severe left ventricular systolic dysfunction may reverse with renal transplantation : uremic cardiomyopathy and cardiorenal syndrome. Am J Transplant 2008 ; 8 (11) : 2219-24.
PubMed
46) Burt RK, Gupta-Burt S, Suki WN, Barcenas CG, Ferguson JJ, Van Buren CT. Reversal of left ventricular dysfunction after renal transplantation. Ann Intern Med 1989 ; 111 (8) : 635-40.
PubMed
47) Melchor JL, Espinoza R, Gracida C. Kidney transplantation in patients with ventricular ejection fraction less than 50 percent : features and posttransplant outcome. Transplant Proc 2002 ; 34 (7) : 2539-40.
PubMed
48) Wali RK, Wang GS, Gottlieb SS, Bellumkonda L, Hansalia R, Ramos E, et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 2005 ; 45 (7) : 1051-60.
PubMed
49) Goto N, Uchida K, Komiya T. Dilated cardiomyopathy and left ventricular hypertrophy in patients with chronic kidney disease is dramaticaly improved by kidney transplantation. Am J Transplant 2008 ; 8 : 595, abstract # 1570
 

10. 糖尿病合併患者に対する術前評価

P.80 掲載の参考文献
1) 日本透析医学会. わが国の慢性透析療法の現況 2013. Available from : http://docs.jsdt.or.jp/overview/pdf2014/p022.pdf.
 
2) 日本移植学会・日本臨床腎移植学会. 腎移植臨床登録集計報告 (2014) 2013年実施症例の集計報告と追跡調査結果. 移植 2014 ; 49 (2-3) : 240-60.
 
3) Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990 ; 39 (9) : 1116-24.
PubMed
4) Pugh JA, Medina R, Ramirez M. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 1993 ; 36 (10) : 1094-8.
PubMed
5) Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999 ; 22 (2) : 233-40.
PubMed
6) Qiao Q, Pyorala K, Pyorala M, Nissinen A, Lindstrom J, Tilvis R, et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002 ; 23 (16) : 1267-75.
PubMed
7) Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992 ; 41 (2) : 202-8.
PubMed
8) DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality : comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001 ; 161 (3) : 397-405.
 
9) Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004 ; 164 (19) : 2147-55.
 
10) Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure : the Framingham study. Am J Cardiol 1974 ; 34 (1) : 29-34.
PubMed
11) Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes : prevalence, incidence, and risk factors. Diabetes Care 2001 ; 24 (9) : 1614-9.
PubMed
12) Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 2004 ; 27 (3) : 699-703.
PubMed
13) Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001 ; 103 (22) : 2668-73.
PubMed
14) Bertoni AG, Tsai A, Kasper EK, Brancati FL. Diabetes and idiopathic cardiomyopathy : a nationwide case-control study. Diabetes Care 2003 ; 26 (10) : 2791-5.
PubMed
15) Barzilay JI, Kronmal RA, Gottdiener JS, Smith NL, Burke GL, Tracy R, et al. The association of fasting glucose levels with congestive heart failure in diabetic adults > or=65 years : the Cardiovascular Health Study. J Am Coll Cardiol 2004 ; 43 (12) : 2236-41.
PubMed
16) Carr AA, Kowey PR, Devereux RB, Brenner BM, Dahlof B, Ibsen H, et al. Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. Am J Cardiol 2005 ; 96 (11) : 1530-6.
PubMed
17) Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease : therapeutic options in patients with diabetes. J Am Coll Cardiol 2000 ; 36 (2) : 355-65.
PubMed
18) Eckel RH, Wassef M, Chait A, Sobel B, Barrett E, King G, et al. Prevention Conference VI : Diabetes and Cardiovascular Disease : Writing Group II : pathogenesis of atherosclerosis in diabetes. Circulation 2002 ; 105 (18) : e138-43.
PubMed
19) Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M, et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996 ; 28 (3) : 573-9.
 
20) Makimattila S, Virkamaki A, Groop PH, Cockcroft J, Utriainen T, Fagerudd J, et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 1996 ; 94 (6) : 1276-82.
PubMed
21) Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003 ; 41 (8) : 1387-93.
PubMed
22) Miura H, Wachtel RE, Loberiza FR Jr, Saito T, Miura M, Nicolosi AC, et al. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles : reduced activity of ATP-sensitive potassium channels. Circ Res 2003 ; 92 (2) : 151-8.
PubMed
23) Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali JR, Valensi P. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 1998 ; 97 (8) : 736-43.
 
24) Winocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992 ; 41 Suppl 2 : 26-31.
 
25) Davi G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990 ; 322 (25) : 1769-74.
PubMed
26) Calverley DC, Hacker MR, Loda KA, Brass E, Buchanan TA, Tsao-Wei DD, et al. Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus. Br J Haematol 2003 ; 121 (1) : 139-42.
PubMed
27) Kwaan HC. Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes. Diabetes 1992 ; 41 Suppl 2 : 32-5.
 
28) Moreno PR, Murcia AM, Palacios IF, Leon MN, Bernardi VH, Fuster V, et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000 ; 102 (18) : 2180-4.
PubMed
29) Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998 ; 339 (4) : 229-34.
PubMed
30) Lee CD, Folsom AR, Pankow JS, Brancati FL. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 2004 ; 109 (7) : 855-60.
PubMed
31) Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 1993 ; 21 (4) : 920-5.
 
32) Niakan E, Harati Y, Rolak LA, Comstock JP, Rokey R. Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med 1986 ; 146 (11) : 2229-30.
PubMed
33) Faerman I, Faccio E, Milei J, Nunez R, Jadzinsky M, Fox D, et al. Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes 1977 ; 26 (12) : 1147-58.
PubMed
34) Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzylguanidine imaging in dia betes mellitus : assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995 ; 25 (3) : 610-8.
 
35) Watkins PJ, Mackay JD. Cardiac denervation in diabetic neuropathy. Ann Intern Med 1980 ; 92 (2 Pt 2) : 304-7.
 
36) Witczak BJ, Hartmann A, Jenssen T, Foss A, Endresen K. Routine coronary angiography in diabetic nephropathy patients before transplantation. Am J Transplant 2006 ; 6 (10) : 2403-8.
PubMed
37) Ramanathan V, Goral S, Tanriover B, Feurer ID, Kazancioglu R, Shaffer D, et al. Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation 2005 ; 79 (10) : 1453-8.
PubMed
38) Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease : identification of a low risk subgroup. Kidney Int 1993 ; 44 (3) : 617-21.
PubMed
39) Ma IW, Valantine HA, Shibata A, Waskerwitz J, Dafoe DC, Alfrey EJ, et al. Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation. Clin Transplant 2006 ; 20 (2) : 139-46.
PubMed
40) Kasiske BL, Israni AK, Snyder JJ, Camarena A. Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST). Am J Kidney Dis 2011 ; 57 (6) : 908-16.
PubMed
41) McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008 ; 51 (15) : 1419-28.
PubMed
42) Gaston RS, Danovitch GM, Adams PL, Wynn JJ, Merion RM, Deierhoi MH, et al. The report of a national conference on the wait list for kidney transplantation. Am J Transplant 2003 ; 3 (7) : 775-85.
PubMed
43) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005 ; 45 (4 Suppl 3) : S1-153.
 
44) Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era : a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2004 ; 109 (4) : 476-80.
 
45) Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995 ; 91 (4) : 979-89.
PubMed
46) Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996 ; 94 (8) : 1818-25.
 
47) Morris JJ, Smith LR, Jones RH, Glower DD, Morris PB, Muhlbaier LH, et al. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation 1991 ; 84 (5 Suppl) : III275-84.
 
48) Smith LR, Harrell FE Jr, Rankin JS, Califf RM, Pryor DB, Muhlbaier LH, et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 1991 ; 84 (5 Suppl) : III245-53.
 
49) Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999 ; 67 (4) : 1045-52.
PubMed
50) Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004 ; 94 (3) : 300-5.
PubMed
51) Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, et al. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 1994 ; 343 (8912) : 1519-22.
PubMed
52) Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease : an update. Hypertension 2001 ; 37 (4) : 1053-9.
PubMed
53) Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992 ; 19 (5) : 403-18.
 
54) Parving HH, Hommel E, Mathiesen E, Skott P, Edsberg B, Bahnsen M, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988 ; 296 (6616) : 156-60.
PubMed
55) Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994 ; 4 (7) : 1486-90.
 
56) Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996 ; 49 (5) : 1379-85.
PubMed
57) Brenner BM, Rector FC. Brenner & Rector's the kidney, 8th ed. Saunders Elsevier, Philadelphia, 2008.
 
58) Stahrenberg R, Edelmann F, Mende M, Kockskamper A, Dungen HD, Scherer M, et al. Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia 2010 ; 53 (7) : 1331-40.
PubMed
59) From AM, Scott CG, Chen HH. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol 2010 ; 55 (4) : 300-5.
PubMed
60) Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 1991 ; 68 (1) : 85-9.
PubMed
61) Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J 1989 ; 118 (5 Pt 1) : 1000-12.
 
62) Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007 ; 115 (25) : 3213-23.
PubMed
63) Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993 ; 88 (6) : 2510-6.
PubMed
64) Sebbag L, Forrat R, Canet E, Wiernsperger N, Delaye J, Renaud S, et al. Effect of experimental non-insulin requiring diabetes on myocardial microcirculation during ischaemia in dogs. Eur J Clin Invest 1994 ; 24 (10) : 686-90.
PubMed
65) van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, et al. Diastolic stiffness of the failing diabetic heart : importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008 ; 117 (1) : 43-51.
PubMed
66) Wheeler TJ. Translocation of glucose transporters in response to anoxia in heart. J Biol Chem 1988 ; 263 (36) : 19447-54.
 
67) Sun D, Nguyen N, DeGrado TR, Schwaiger M, Brosius FC III. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation 1994 ; 89 (2) : 793-8.
 
68) Floege J. When man turns to stone : extraosseous calcification in uremic patients. Kidney Int 2004 ; 65 (6) : 2447-62.
PubMed
69) Forman MB, Virmani R, Robertson RM, Stone WJ. Mitral anular calcification in chronic renal failure. Chest 1984 ; 85 (3) : 367-71.
PubMed
70) Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 1992 ; 67 (3) : 236-9.
PubMed
71) Nestico PF, Depace NL, Morganroth J, Kotler MN, Ross J. Mitral annular calcification : clinical, pathophysiology, and echocardiographic review. Am Heart J 1984 ; 107 (5 Pt 1) : 989-96.
 
72) Rubel JR, Milford EL. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population. Am J Kidney Dis 2003 ; 41 (2) : 411-21.
PubMed
73) Kajbaf S, Veinot JP, Ha A, Zimmerman D. Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am J Kidney Dis 2005 ; 46 (1) : 86-93.
PubMed
74) Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999 ; 341 (23) : 1725-30.
PubMed
75) Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation : the challenge of diabetes. Am J Transplant 2008 ; 8 (3) : 593-9.
PubMed
76) Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000 ; 58 (3) : 1311-7.
PubMed
77) Gaston RS, Basadonna G, Cosio FG, Davis CL, Kasiske BL, Larsen J, et al. Transplantation in the diabetic patient with advanced chronic kidney disease : a task force report. Am J Kidney Dis 2004 ; 44 (3) : 529-42.
PubMed
78) Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987 ; 59 (8) : 750-5.
PubMed
79) Barrett-Connor E, Orchard TJ. Insulin-dependent diabetes mellitus and ischemic heart disease. Diabetes Care 1985 ; 8 Suppl 1 : 65-70.
 
80) Kandaswamy R, Stock PG, Skeans MA, Gustafson SK, Sleeman EF, Wainright JL, et al. OPTN/SRTR 2011 Annual Data Report : pancreas. Am J Transplant 2013 ; 13 Suppl 1 : 47-72.
 
81) Young BY, Gill J, Huang E, Takemoto SK, Anastasi B, Shah T, et al. Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics : an analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol 2009 ; 4 (4) : 845-52.
PubMed
82) 日本膵・膵島移植研究会膵臓移植班. 本邦膵移植症例登録報告 (2014). 移植 2014 ; 49 (2-3) : 285-91.
 
P.85 掲載の参考文献
1) Ogata N, et al. Safety margin of minimized contrast volume during percutaneous coronary intervention in patients with chronic kidney disease. Cardiovasc Interv Ther 2014 ; 29 (3) : 209-15.
PubMed

11. 先行的腎移植

P.90 掲載の参考文献
1) OPTN/SRTR 2012 Annual Data Report. Available from : http://srtr.transplant.hrsa.gov/annual_reports/2012/pdf/01_kidney_13.pdf.
 
2) 日本移植学会・日本臨床腎移植学会. 腎移植臨床登録集計報告 (2014) 2013年実施症例の集計報告と追跡調査結果. 移植 2014 ; 49 (2-3) : 240-60.
 
3) Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, et al. Kidney transplantation as primary therapy for end-stage renal disease : a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol 2008 ; 3 (2) : 471-80.
PubMed
4) Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001 ; 344 (10) : 726-31.
 
5) Vats AN, Donaldson L, Fine RN, Chavers BM. Pretransplant dialysis status and outcome of renal transplantation in North American children : a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study. Transplantation 2000 ; 69 (7) : 1414-9.
PubMed
6) Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000 ; 58 (3) : 1311-7.
PubMed
7) Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes : a paired donor kidney analysis. Transplantation 2002 ; 74 (10) : 1377-81.
PubMed
8) Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT. Preemptive kidney transplantation : the advantage and the advantaged. J Am Soc Nephrol 2002 ; 13 (5) : 1358-64.
PubMed
9) Jung GO, Moon JI, Kim JM, Choi GS, Kwon CH, Cho JW, et al. Can preemptive kidney transplantation guarantee longer graft survival in living-donor kidney transplantation? Single-center study. Transplant Proc 2010 ; 42 (3) : 766-74.
PubMed
10) Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, et al. Experience from an active preemptive kidney transplantation program--809 cases revisited. Transplantation 2009 ; 88 (5) : 672-7.
PubMed
11) Cransberg K, Smits JM, Offner G, Nauta J, Persijn GG. Kidney transplantation without prior dialysis in children : the Eurotransplant experience. Am J Transplant 2006 ; 6 (8) : 1858-64.
PubMed
12) Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States : the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003 ; 14 (12) : 3270-7.
PubMed
13) Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 ; 351 (13) : 1296-305.
PubMed
14) Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 2004 ; 4 (10) : 1662-8.
PubMed
15) McGregor E, Stewart G, Rodger RS, Jardine AG. Early echocardiographic changes and survival following renal transplantation. Nephrol Dial Transplant 2000 ; 15 (1) : 93-8.
PubMed
16) Chen SC, Su HM, Hung CC, Chang JM, Liu WC, Tsai JC, et al. Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol 2011 ; 6 (12) : 2750-8.
PubMed
17) Foley RN, Curtis BM, Randell EW, Parfrey PS. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 2010 ; 5 (5) : 805-13.
PubMed
18) Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, et al. Left ventricular mass index increase in early renal disease : impact of decline in hemoglobin. Am J Kidney Dis 1999 ; 34 (1) : 125-34.
PubMed
19) Ishani A, Ibrahim HN, Gilbertson D, Collins AJ. The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants. Am J Kidney Dis 2003 ; 42 (6) : 1275-82.
PubMed
20) Akkina SK, Connaire JJ, Snyder JJ, Matas AJ, Kasiske BL. Earlier is not necessarily better in preemptive kidney transplantation. Am J Transplant 2008 ; 8 (10) : 2071-6.
 
21) K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Am J Kidney Dis 2002 ; 39 (2 Suppl 1) : S1-266.
 
22) Gaston RS, Basadonna G, Cosio FG, Davis CL, Kasiske BL, Larsen J, et al. Transplantation in the diabetic patient with advanced chronic kidney disease : a task force report. Am J Kidney Dis 2004 ; 44 (3) : 529-42.
PubMed
23) Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988 ; 84 (6) : 985-92.
PubMed
24) Gill JS, Ma I, Landsberg D, Johnson N, Levin A. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol 2005 ; 16 (3) : 808-16.
PubMed
25) Charytan DM, Wallentin L, Lagerqvist B, Spacek R, De Winter RJ, Stern NM, et al. Early angiography in patients with chronic kidney disease : a collaborative systematic review. Clin J Am Soc Nephrol 2009 ; 4 (6) : 1032-43.
PubMed
26) Lorenz EC, Stegall MD, Cosio FG, Gloor JM, Larson TS, Taler SJ. The effect of coronary angiography on renal function in preemptive renal transplant candidates. Clin Transplant 2011 ; 25 (4) : 594-9.
PubMed

12. 脳卒中

P.98 掲載の参考文献
1) Shinohara Y. Regional differences in incidence and management of stroke : is there any difference between Western and Japanese guidelines on antiplatelet therapy? Cerebrovasc Dis 2006 ; 21 Suppl 1 : 17-24.
 
2) 小林祥泰. 脳卒中データバンク2009, 中山書店, 東京, 2009
 
3) 厚生労働省. 死因簡単分類別にみた性別死亡数・死亡率 (人口10万対), 2011. Available from : http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei11/dl/11_h7.pdf.
 
4) 藤島正敏. 高齢者の心血管病-久山町研究から. 日老年医学誌 1999 ; 36 (1) : 16-21.
 
5) Tanaka H, Ueda Y, Hayashi M, et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982 ; 13 (1) : 62-73.
 
6) Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure : overview of randomised drug trials in their epidemiological context. Lancet 1990 ; 335 (8693) : 827-38.
PubMed
7) Arvanitakis Z, Schneider JA, Wilson RS, et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 2006 ; 67 (11) : 1960-5.
 
8) Janghorbani M, Hu FB, Willett WC, et al. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes : the Nurses' Health Study. Diabetes Care 2007 ; 30 (7) : 1730-5.
PubMed
9) Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease : a collaborative meta-analysis of 102 prospective studies. Lancet 2010 ; 375 (9733) : 2215-22.
PubMed
10) Luitse MJ, Biessels GJ, Rutten GE, et al. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012 ; 11 (3) : 261-71.
PubMed
11) Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men : a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet 2014 ; 383 (9933) : 1973-80.
 
12) Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke : a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997 ; 96 (9) : 3243-7.
PubMed
13) Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993 ; 269 (2) : 232-6.
PubMed
14) Kurth T, Kase CS, Berger K, et al. Smoking and risk of hemorrhagic stroke in women. Stroke 2003 ; 34 (12) : 2792-5.
PubMed
15) Wilson PW, Hoeg JM, D'Agostino RB, et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 1997 ; 337 (8) : 516-22.
PubMed
16) Li C, Engstrom G, Hedblad B, et al. Risk factors for stroke in subjects with normal blood pressure : a prospective cohort study. Stroke 2005 ; 36 (2) : 234-8.
PubMed
17) Wolf PA, D'Agostino RB, Kannel WB, et al. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988 ; 259 (7) : 1025-9.
PubMed
18) Peters SA, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared with men : a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke 2013 ; 44 (10) : 2821-8.
 
19) Piechowski-Jozwiak B, Bogousslavsky J. Cholesterol as a risk factor for stroke : the fugitive? Stroke 2004 ; 35 (6) : 1523-4.
PubMed
20) Thrift AG. Cholesterol is associated with stroke, but is not a risk factor. Stroke 2004 ; 35 (6) : 1524-5.
 
21) Donnan GA, Davis SM. Stroke and cholesterol : weakness of risk versus strength of therapy. Stroke 2004 ; 35 (6) : 1526.
PubMed
22) 藤島正. 日本人の脳血管障害. 日内会誌 1996 ; 85 (臨増) : 56-60.
 
23) Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke : the Framingham Study. Stroke 1991 ; 22 (8) : 983-8.
PubMed
24) Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population : the Hisayama Study. Kidney Int 2005 ; 68 (1) : 228-36.
 
25) Irie F, Iso H, Sairenchi T, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 2006 ; 69 (7) : 1264-71.
PubMed
26) Nakayama M, Metoki H, Terawaki H, et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population : the Ohasama study. Nephrol Dial Transplant 2007 ; 22 (7) : 1910-5.
 
27) Kokubo Y, Nakamura S, Okamura T, et al. Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease : the Suita Study. Stroke 2009 ; 40 (8) : 2674-9.
 
28) Lee M, Saver JL, Chang KH, et al. Low glomerular filtration rate and risk of stroke : meta-analysis. BMJ 2010 ; 341 : c4249.
PubMed
29) Molshatzki N, Orion D, Tsabari R, et al. Chronic kidney disease in patients with acute intracerebral hemorrhage : association with large hematoma volume and poor outcome. Cerebrovasc Dis 2011 ; 31 (3) : 271-7.
PubMed
30) Kumai Y, Kamouchi M, Hata J, et al. Proteinuria and clinical outcomes after ischemic stroke. Neurology 2012 ; 78 (24) : 1909-15.
PubMed
31) Tsukamoto Y, Takahashi W, Takizawa S, et al. Chronic kidney disease in patients with ischemic stroke. J Stroke Cerebrovasc Dis 2012 ; 21 (7) : 547-50.
PubMed
32) Iguchi Y, Kimura K, Kobayashi K, et al. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol 2008 ; 102 (8) : 1056-9.
PubMed
33) Go AS, Fang MC, Udaltsova N, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation : the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009 ; 119 (10) : 1363-9.
PubMed
34) Kawamura M, Fijimoto S, Hisanaga S, et al. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis 1998 ; 31 (6) : 991-6.
PubMed
35) Iseki K, Fukiyama K. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. Nephrol Dial Transplant 2000 ; 15 (11) : 1808-13.
PubMed
36) Wiesholzer M, Harm F, Tomasec G, et al. Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol 2001 ; 21 (1) : 35-9.
PubMed
37) Seliger SL, Gillen DL, Tirschwell D, et al. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 2003 ; 14 (10) : 2623-31.
PubMed
38) Saposnik G, Kapral MK, Liu Y, et al. IScore : a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation 2011 ; 123 (7) : 739-49.
PubMed
39) Yahalom G, Schwartz R, Schwammenthal Y, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 2009 ; 40 (4) : 1296-303.
PubMed
40) Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis : a 22-year single-center study. Am J Kidney Dis 2005 ; 45 (6) : 1058-66.
PubMed
41) Naganuma M, Koga M, Shiokawa Y, et al. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA : the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis 2011 ; 31 (2) : 123-9.
PubMed
42) Onoyama K, Kumagai H, Miishima T, et al. Incidence of strokes and its prognosis in patients on maintenance hemodialysis. Jpn Heart J 1986 ; 27 (5) : 685-91.
PubMed
43) Ueda K, Hasuo Y, Kiyohara Y, et al. Intracerebral hemorrhage in a Japanese community, Hisayama : incidence, changing pattern during long-term follow-up, and related factors. Stroke 1988 ; 19 (1) : 48-52.
 
44) Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990 ; 21 (4) : 637-76.
PubMed
45) Kubo M, Kiyohara Y, Ninomiya T, et al. Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population. Neurology 2006 ; 66 (10) : 1539-44.
 
46) Kobayashi S. International experience in stroke registry : Japanese Stroke Databank. Am J Prev Med 2006 ; 31 (6 Suppl 2) : S240-2.
 
47) Sacco SE, Whisnant JP, Broderick JP, et al. Epidemiological characteristics of lacunar infarcts in a population. Stroke 1991 ; 22 (10) : 1236-41.
 
48) Jackson C, Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 2005 ; 128 (Pt 11) : 2507-17.
 
49) Vazquez E, Sanchez-Perales C, Borrego F, et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 2000 ; 140 (6) : 886-90.
PubMed
50) Abbott KC, Trespalacios FC, Taylor AJ, et al. Atrial fibrillation in chronic dialysis patients in the United States : risk factors for hospitalization and mortality. BMC Nephrol 2003 ; 4 : 1.
PubMed
51) Sanchez-Perales C, Vazquez E, Garcia-Cortes MJ, et al. Ischaemic stroke in incident dialysis patients. Nephrol Dial Transplant 2010 ; 25 (10) : 3343-8.
 
52) Vazquez-Ruiz de Castroviejoa E, Sanchez-Perales C, Lozano-Cabezas C, et al. Incidence of atrial fibrillation in hemodialysis patients : a prospective long-term follow-up study. Rev Esp Cardiol 2006 ; 59 (8) : 779-84.
PubMed
53) Wright CB, Paik MC, Brown TR, et al. Total homocysteine is associated with white matter hyperintensity volume : the Northern Manhattan Study. Stroke 2005 ; 36 (6) : 1207-11.
PubMed
54) Censori B, Partziguian T, Manara O, et al. Plasma homocysteine and severe white matter disease. Neurol Sci 2007 ; 28 (5) : 259-63.
PubMed
55) Oliveras A, Roquer J, Puig JM, et al. Stroke in renal transplant recipients : epidemiology, predictive risk factors and outcome. Clin Transplant 2003 ; 17 (1) : 1-8.
PubMed
56) Abedini S, Holme I, Fellstrom B, et al. Cerebrovascular events in renal transplant recipients. Transplantation 2009 ; 87 (1) : 112-7.
PubMed

13. 末梢動脈疾患

P.107 掲載の参考文献
1) Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) : a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) : endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation ; National Heart, Lung, and Blood Institute ; Society for Vascular Nursing ; TransAtlantic Inter-Society Consensus ; and Vascular Disease Foundation. Circulation 2006 ; 113 (11) : e463-654.
 
2) O'Hare AM, Glidden DV, Fox CS, et al. High prevalence of peripheral arterial disease in persons with renal insufficiency : results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2004 ; 109 (3) : 320-3.
PubMed
3) O'Hare AM, Vittinghoff E, Hsia J, et al. Renal insufficiency and the risk of lower extremity peripheral arterial disease : results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 2004 ; 15 (4) : 1046-51.
 
4) Wattanakit K, Folsom AR, Selvin E, et al. Kidney function and risk of peripheral arterial disease : results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007 ; 18 (2) : 629-36.
PubMed
5) Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007 ; 45 Suppl S : S5-67.
 
6) O'Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001 ; 12 (12) : 2838-47.
PubMed
7) Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000 ; 58 (1) : 353-62.
PubMed
8) O'Hare AM, Hsu CY, Bacchetti P, et al. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002 ; 13 (2) : 497-503.
PubMed
9) Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Peripheral arterial disease in patients with end-stage renal disease : observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 2006 ; 114 (18) : 1914-22.
PubMed
10) Fishbane S, Youn S, Flaster E, et al. Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 1996 ; 27 (5) : 668-72.
PubMed
11) Testa A, Ottavioli JN. Ankle-arm blood pressure index (AABPI) in hemodialysis patients. Arch Mal Coeur Vaiss 1998 ; 91 (8) : 963-5.
PubMed
12) Okamoto K, Oka M, Maesato K, et al. Peripheral arterial occlusive disease is more prevalent in patients with hemodialysis : comparison with the findings of multidetector-row computed tomography. Am J Kidney Dis 2006 ; 48 (2) : 269-76.
PubMed
13) Bernstein EF, Fronek A. Current status of noninvasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am 1982 ; 62 (3) : 473-87.
PubMed
14) Sung RS, Althoen M, Howell TA, et al. Peripheral vascular occlusive disease in renal transplant recipients : risk factors and impact on kidney allograft survival. Transplantation 2000 ; 70 (7) : 1049-54.
PubMed
15) Brar A, Jindal RM, Elster EA, et al. Effect of peripheral vascular disease on kidney allograft outcomes : a study of U. S. Renal data system. Transplantation 2013 ; 95 (6) : 810-5.
PubMed
16) Hertzer NR. Basic data concerning associated coronary disease in peripheral vascular patients. Ann Vasc Surg 1987 ; 1 (5) : 616-20.
PubMed
17) Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients : a classification of 1,000 coronary angiograms and results of surgical management. Ann Surg 1984 ; 199 (2) : 223-33.
 
18) Leskinen Y, Salenius JP, Lehtimaki T, et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure : requirements for diagnostics. Am J Kidney Dis 2002 ; 40 (3) : 472-9.
PubMed
19) Grisafi JL, Dadachanji C, Rahbar R, et al. The effect of immunosuppression on lower extremity arterial bypass outcomes. Ann Vasc Surg 2011 ; 25 (2) : 165-8.
PubMed
20) Lakier JB. Smoking and cardiovascular disease. Am J Med 1992 ; 93 (1A) : 8 S-12 S.
 
21) 渋谷祐一. 【長期透析患者の腎移植における諸問題】長期透析患者の腎移植術 : 血行再建における問題点. 腎移植・血管外科 2012 ; 24 (2) : 118-22.
 
22) Akbari CM, LoGerfo FW. Diabetes and peripheral vascular disease. J Vasc Surg 1999 ; 30 (2) : 373-84.
PubMed

14. 高齢者の腎移植

P.114 掲載の参考文献
1) Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007 ; 11 (2) : 156-63.
PubMed
2) 日本透析医学会. わが国の慢性透析療法の現況2013年12月31日現在. Available from : http://docs.jsdt.or.jp/overview/pdf2014/p010.pdf.
 
3) OPTN & SRTR 2011 Annual Data Report, 2011. Scientific Registry of Transplant Recipients. Available from : http://srtr.transplant.hrsa.gov/annual_reports/2011/default.aspx
 
4) Schaeffner ES, Rose C, Gill JS. Access to kidney transplantation among the elderly in the United States : a glass half full, not half empty. Clin J Am Soc Nephrol 2010 ; 5 (11) : 2109-14.
 
5) 日本移植学会・日本臨床腎移植学会. 腎移植臨床登録集計報告 (2014) 2013年実施症例の集計報告と追跡調査結果. 移植 2014 ; 49 (2-3) : 240-60.
 
6) Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999 ; 341 (23) : 1725-30.
PubMed
7) Hunsicker LG. A survival advantage for renal transplantation. N Engl J Med 1999 ; 341 (23) : 1762-3.
PubMed
8) Johnson DW, Herzig K, Purdie D, et al. A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation 2000 ; 69 (5) : 794-9.
 
9) Oniscu GC, Brown H, Forsythe JL. How great is the survival advantage of transplantation over dialysis in elderly patients? Nephrol Dial Transplant 2004 ; 19 (4) : 945-51.
 
10) Giessing M, Budde K, Fritsche L, et al. "Old-for-old"cadaveric renal transplantation : surgical findings, perioperative complications and outcome. Eur Urol 2003 ; 44 (6) : 701-8.
PubMed
11) Rao PS, Merion RM, Ashby VB, et al. Renal transplantation in elderly patients older than 70 years of age : results from the Scientific Registry of Transplant Recipients. Transplantation 2007 ; 83 (8) : 1069-74.
PubMed
12) Savoye E, Tamarelle D, Chalem Y, et al. Survival benefits of kidney transplantation with expanded criteria deceased donors in patients aged 60 years and over. Transplantation 2007 ; 84 (12) : 1618-24.
PubMed
13) OPTN & SRTR 2009 Annal Data Report, 2009. Available from : The 2010 SRTR report on the state of transplantation (www.ustransplant.org/annual_reports).
 
14) Tullius SG, Tran H, Guleria I, et al. The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. Ann Surg 2010 ; 252 (4) : 662-74.
PubMed
15) Meier-Kriesche HU, Cibrik DM, Ojo AO, et al. Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc 2002 ; 50 (1) : 14-7.
PubMed
16) Martins PN, Pratschke J, Pascher A, et al. Age and immune response in organ transplantation. Transplantation 2005 ; 79 (2) : 127-32.
PubMed
17) Trouillhet I, Benito N, Cervera C, et al. Influence of age in renal transplant infections : cases and controls study. Transplantation 2005 ; 80 (7) : 989-92.
PubMed
18) Karim A, Farrugia D, Cheshire J, et al. Recipient age and risk for mortality after kidney transplantation in England. Transplantation 2014 ; 97 (8) : 832-8.
PubMed
19) Velez RL, Brinker KR, Vergne-Marini PJ, et al. Renal transplantation with cyclosporine in the elderly population. Transplant Proc 1991 ; 23 (2) : 1749-52.
PubMed
20) European best practice guidelines for renal transplantation. Section IV : Long-term management of the transplant recipient. IV. 12. Elderly (specific problems). Nephrol Dial Transplant 2002 ; 17 Suppl 4 : 58-60.
 
21) Danovitch GM, Gill J, Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation 2007 ; 84 (3) : 285-91.
PubMed
22) Keith DS, Demattos A, Golconda M, et al. Effect of donor recipient age match on survival after first deceased donor renal transplantation. J Am Soc Nephrol 2004 ; 15 (4) : 1086-91.
PubMed
23) Fritsche L, Horstrup J, Budde K, et al. Old-for-old kidney allocation allows successful expansion of the donor and recipient pool. Am J Transplant 2003 ; 3 (11) : 1434-9.
PubMed
24) Gill J, Bunnapradist S, Danovitch GM, et al. Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis 2008 ; 52 (3) : 541-52.
PubMed
25) Molnar MZ, Streja E, Kovesdy CP, et al. Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis 2012 ; 59 (6) : 841-8.
PubMed
26) Frei U, Noeldeke J, Machold-Fabrizii V, et al. Prospective age-matching in elderly kidney transplant recipients : a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008 ; 8 (1) : 50-7.
PubMed
27) 後藤憲彦. 高齢腎不全患者の腎移植を再考する-高齢者間腎移植の話題を中心に-. Mebio 2014 ; 31 (11) : 26-30.
Medical*Online
28) Ismail N, Hakim RM, Helderman JH. Renal replacement therapies in the elderly : Part II. Renal transplantation. Am J Kidney Dis 1994 ; 23 (1) : 1-15.
PubMed
29) Fabrizii V, Winkelmayer WC, Klauser R, et al. Patient and graft survival in older kidney transplant recipients : does age matter? J Am Soc Nephrol 2004 ; 15 (4) : 1052-60.
 

15. 術前の冠危険因子管理

P.121 掲載の参考文献
1) Lynch RJ, Ranney DN, Shijie C, et al. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009 ; 250 (6) : 1014-20.
PubMed
2) Hortal L, Fernandez A, Losada A, et al. Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index. Transplant Proc 2001 ; 33 (7-8) : 3110-1.
 
3) Molnar MZ, Kovesdy CP, Mucsi I, et al. Higher recipient body mass index is associated with post-transplant delayed kidney graft function. Kidney Int 2011 ; 80 (2) : 218-24.
PubMed
4) Gore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant 2006 ; 6 (2) : 357-63.
PubMed
5) Hoogeveen EK, Aalten J, Rothman KJ, et al. Effect of obesity on the outcome of kidney transplantation : a 20-year follow-up. Transplantation 2011 ; 91 (8) : 869-74.
PubMed
6) 日本臨床腎移植学会 (編). 腎移植後内科・小児科系合併症の診療ガイドライン2011. 日本医学館, 東京, 2011
 
7) Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 2006 ; 17 (5) : 1453-9.
PubMed
8) Segev DL, Simpkins CE, Thompson RE, et al. Obesity impacts access to kidney transplantation. J Am Soc Nephrol 2008 ; 19 (2) : 349-55.
 
9) 日本肥満学会. 肥満症治療ガイドライン2006. 肥満研究 2006 ; 12 (臨増).
 
10) Kopple JD, Monteon FJ, Shaib JK. Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure. Kidney Int 1986 ; 29 (3) : 734-42.
PubMed
11) 日本腎臓学会 (編). 慢性腎臓病に対する食事療法基準2014年版. 日本腎臓学会誌 2014 ; 56 (5) : 553-599.
 
12) Bennett WM, McEvoy KM, Henell KR, et al. Kidney transplantation in the morbidly obese : complicated but still better than dialysis. Clin Transplant 2011 ; 25 (3) : 401-5.
PubMed
13) WHO. Risk factors : Tobacco Data by country 2014 [cited 2014 Aug 10th] . Available from : http://apps.who.int/gho/data/node.main.65.
 
14) 厚生労働省. 平成24年国民健康・栄養調査報告2014 [cited 2014 Aug 10th] . Available from : http://www.mhlw.go.jp/bunya/kenkou/eiyou/dl/h24-houkoku-06.pdf.
 
15) Jee SH, Suh I, Kim IS, et al. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol : the Korea Medical Insurance Corporation Study. JAMA 1999 ; 282 (22) : 2149-55.
PubMed
16) Qiao Q, Tervahauta M, Nissinen A, et al. Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J 2000 ; 21 (19) : 1621-6.
 
17) Foody JM, Cole CR, Blackstone EH, et al. A propensity analysis of cigarette smoking and mortality with consideration of the effects of alcohol. Am J Cardiol 2001 ; 87 (6) : 706-11.
PubMed
18) 日本透析医学会. わが国の慢性透析療法の現況2012年12月31日現在. 2013. Available from : http://docs.jsdt.or.jp/overview/pdf2013/p060.pdf.
 
19) Liebman SE, Lamontagne SP, Huang LS, et al. Smoking in dialysis patients : a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis 2011 ; 58 (2) : 257-65.
PubMed
20) Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 2012 ; 10 : CD008286.
PubMed
21) Suls JM, Luger TM, Curry SJ, et al. Efficacy of smoking-cessation interventions for young adults : a meta-analysis. Am J Prev Med 2012 ; 42 (6) : 655-62.
PubMed
22) K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005 ; 45 (4 Suppl 3) : S1-153.
 
23) 日本透析医学会. 血液透析患者の糖尿病治療ガイド 2012. 透析会誌 2013 ; 46 (3) : 311-57.
 
24) National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD : 2012 Update. Am J Kidney Dis 2012 ; 60 (5) : 850-86.
PubMed
25) Chapter 1 : Definition and classification of CKD. Kidney Int Suppl (2011) 2013 ; 3 (1) : 19-62.
 
26) Whaley-Connell AT, Sowers JR, Stevens LA, et al. CKD in the United States : Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008 ; 51 (4 Suppl 2) : S13-20.
 
27) Zucchelli P, Santoro A, Zuccala A. Genesis and control of hypertension in hemodialysis patients. Semin Nephrol 1988 ; 8 (2) : 163-8.
PubMed
28) Rocco MV, Flanigan MJ, Beaver S, et al. Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group. Am J Kidney Dis 1997 ; 30 (2) : 165-73.
 
29) Rahman M, Dixit A, Donley V, et al. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis 1999 ; 33 (3) : 498-506.
PubMed
30) Agarwal R, Nissenson AR, Batlle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 2003 ; 115 (4) : 291-7.
PubMed
31) Neumann J, Ligtenberg G, Klein, II, et al. Sympathetic hyperactivity in chronic kidney disease : pathogenesis, clinical relevance, and treatment. Kidney Int 2004 ; 65 (5) : 1568-76.
PubMed
32) Raine AE, Bedford L, Simpson AW, et al. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int 1993 ; 43 (3) : 700-5.
PubMed
33) Passauer J, Pistrosch F, Bussemaker E, et al. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. J Am Soc Nephrol 2005 ; 16 (4) : 959-65.
 
34) 日本高血圧学会高血圧治療ガイドライン作成委員会 (編). 高血圧治療ガイドライン 2014. ライフサイエンス出版, 東京, 2014
 
35) 日本腎臓学会 (編). エビデンスに基づくCKD診療ガイドライン 2013. 東京医学社, 東京, 2013
 
36) Zager PG, Nikolic J, Brown RH, et a"l. U"curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 1998 ; 54 (2) : 561-9.
 
37) Robinson BM, Tong L, Zhang J, et al. Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2012 ; 82 (5) : 570-80.
PubMed
38) Agarwal R, Alborzi P, Satyan S, et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP) : a randomized, controlled trial. Hypertension 2009 ; 53 (3) : 500-7.
PubMed
39) Mangray M, Vella JP. Hypertension after kidney transplant. Am J Kidney Dis 2011 ; 57 (2) : 331-41.
PubMed
40) Paoletti E, Gherzi M, Amidone M, et al. Association of arterial hypertension with renal target organ damage in kidney transplant recipients : the predictive role of ambulatory blood pressure monitoring. Transplantation 2009 ; 87 (12) : 1864-9.
PubMed
41) Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004 ; 43 (6) : 1071-81.
PubMed
42) 日本動脈硬化学会. 動脈硬化性疾患予防ガイドライン 2012年版. 杏林舎, 東京, 2012
 
43) Wanner C, Tonelli M. KDIGO Clinical Practice Guideline for Lipid Management in CKD : summary of recommendation statements and clinical approach to the patient. Kidney Int 2014 ; 85 (6) : 1303-9.
 
44) Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients : a meta-analysis. JAMA 2013 ; 310 (16) : 1711-20.
PubMed
45) Smith SC, Jr., Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease : 2011 update : a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011 ; 124 (22) : 2458-73.
 
46) Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010 ; 59 (RR-8) : 1-62.
PubMed
47) Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions : recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012 ; 61 (40) : 816-9.
PubMed
48) Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014 ; 58 (3) : e44-100.
PubMed

16. 周術期管理

P.129 掲載の参考文献
1) Wolfsthal SD. Is blood pressure control necessary before surgery? Med Clin North Am 1993 ; 77 (2) : 349-63.
PubMed
2) Goldman L, Caldera DL. Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology 1979 ; 50 (4) : 285-92.
PubMed
3) Prys-Rroberts C. Anaesthesia and hypertension. Br J Anaesth 1984 ; 56 (7) : 711-24.
PubMed
4) Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery : executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002 ; 105 (10) : 1257-67.
 
5) Beattie WS, Wijeysundera DN, Karkouti K, et al. Acute surgical anemia influences the cardioprotective effects of beta-blockade : a single-center, propensity-matched cohort study. Anesthesiology 2010 ; 112 (1) : 25-33.
PubMed
6) Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management : The Joint Task Force on non-cardiac surgery : cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014 ; 35 (35) : 2383-431.
 
7) London MJ, Hur K, Schwartz GG, et al. Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013 ; 309 (16) : 1704-13.
PubMed
8) Gal TJ, Cooperman LH. Hypertension in the immediate postoperative period. Br J Anaesth 1975 ; 47 (1) : 70-4.
PubMed
9) Terada T, Hirano Y, Yoshida K, et al. Cardiovascular effects of human atrial natriuretic peptide during renal transplantation. Masui 2005 ; 54 (2) : 144-8.
PubMed
10) Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995 ; 25 (5) : 1111-9.
PubMed
11) Bloomfield P, Wheatley DJ, Prescott RJ, et al. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 1991 ; 324 (9) : 573-9.
PubMed
12) Hammermeister KE, Sethi GK, Henderson WG, et al. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med 1993 ; 328 (18) : 1289-96.
PubMed
13) Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke : results from the National Registry of Atrial Fibrillation. JAMA 2001 ; 285 (22) : 2864-70.
 
14) 日本循環器学会. 循環器疾患における抗凝固・抗血小板療法に関するガイドライン (2011/12/21更新版). 2011. Available from : http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf.
 
15) Hart RG, Pearce LA, Rothbart RM, et al. Stroke with intermittent atrial fibrillation : incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000 ; 35 (1) : 183-7.
PubMed
16) 日本透析医学会. 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌 2011 ; 44 (5) : 337-425.
 
17) King SB III, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines : 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008 ; 117 (2) : 261-95.
 
18) Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) : a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) : endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation ; National Heart, Lung, and Blood Institute ; Society for Vascular Nursing ; TransAtlantic Inter-Society Consensus ; and Vascular Disease Foundation. Circulation 2006 ; 113 (11) : e463-654.
 
19) Regensteiner JG, Ware JE Jr, McCarthy WJ, et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease : meta-analysis of six randomized controlled trials. J Am Geriatr Soc 2002 ; 50 (12) : 1939-46.
PubMed
20) Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000 ; 31 (1 Pt 2) : S1-S296.
 
21) Jackson MR, Clagett GP. Antithrombotic therapy in peripheral arterial occlusive disease. Chest 2001 ; 119 (1 Suppl) : 283S-99S.
 
22) Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007 ; 45 Suppl S : S5-67.
 
23) Nicolau DP, Uber WE, Crumbley AJ III, et al. Amiodarone-cyclosporine interaction in a heart transplant patient. J Heart Lung Transplant 1992 ; 11 (3 Pt 1) : 564-8.
 
24) Chitwood KK, Abdul-Haqq AJ, Heim-Duthoy KL. Cyclosporine-amiodarone interaction. Ann Pharmacother 1993 ; 27 (5) : 569-71.
PubMed
25) Kisters K, Cziborra M, Funke C, et al. Amiodarone-tacrolimus interaction in kidney transplantation. Clin Nephrol 2008 ; 70 (6) : 563.
PubMed
26) 日本透析医学会. 慢性腎臓病患者における腎性貧血治療のガイドライン. 透析会誌 2008 ; 41 (10) : 661-716.
 
27) Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006 ; 355 (20) : 2085-98.
PubMed
28) Drueke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006 ; 355 (20) : 2071-84.
PubMed
29) Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009 ; 361 (21) : 2019-32.
 
30) Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999 ; 340 (6) : 409-17.
 

17. 冠危険因子と冠動脈疾患の移植後管理

P.138 掲載の参考文献
1) Kobus G, Malyszko J, Malyszko JS, et al. Compliance with lifestyle recommendations in kidney allograft recipients. Transplant Proc 2011 ; 43 (8) : 2930-4.
PubMed
2) Villareal DT, Chode S, Parimi N, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 2011 ; 364 (13) : 1218-29.
 
3) 日本肥満学会. 肥満症治療ガイドライン 2006. 肥満研究 2006 ; 12 (臨増).
 
4) De Sevaux RG, Hoitsma AJ, Corstens FH, et al. Treatment with vitamin D and calcium reduces bone loss after renal transplantation : a randomized study. J Am Soc Nephrol 2002 ; 13 (6) : 1608-14.
PubMed
5) Julian BA, Laskow DA, Dubovsky J, et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991 ; 325 (8) : 544-50.
PubMed
6) Adams JE. Renal bone disease : radiological investigation. Kidney Int Suppl 1999 ; 73 : S38-41.
PubMed
7) Vautour LM, Melton LJ III, Clarke BL, et al. Long-term fracture risk following renal transplantation : a population-based study. Osteoporos Int 2004 ; 15 (2) : 160-7.
 
8) Qaseem A, Vijan S, Snow V, et al. Glycemic control and type 2 diabetes mellitus : the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med 2007 ; 147 (6) : 417-22.
PubMed
9) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009 ; 9 Suppl 3 : S1-155.
 
10) 日本臨床腎移植学会. 腎移植後内科・小児科系合併症の診療ガイドライン 2011,日本医学館, 東京, 2011.
 
11) Owda AK, Abdallah AH, Haleem A, et al. De novo diabetes mellitus in kidney allografts : nodular sclerosis and diffuse glomerulosclerosis leading to graft failure. Nephrol Dial Transplant 1999 ; 14 (8) : 2004-7.
PubMed
12) Siddqi N HS, Danovitch G. Handbook of Kidney Transplantation, 4th ed. Lippincott Williams & Wilkins, Philadelphia, 2008.
 
13) Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 ; 358 (24) : 2545-59.
PubMed
14) Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 ; 358 (24) : 2560-72.
PubMed
15) Ismail-Beigi F. Clinical practice. Glycemic management of type 2 diabetes mellitus. N Engl J Med 2012 ; 366 (14) : 1319-27.
PubMed
16) Yates CJ, Fourlanos S, Hjelmesaeth J, et al. New-onset diabetes after kidney transplantation-changes and challenges. Am J Transplant 2012 ; 12 (4) : 820-8.
PubMed
17) Ajabnoor MA, El-Naggar MM, Elayat AA, et al. Functional and morphological study of cultured pancreatic islets treated with cyclosporine. Life Sci 2007 ; 80 (4) : 345-55.
PubMed
18) Oetjen E, Baun D, Beimesche S, et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice. Mol Pharmacol 2003 ; 63 (6) : 1289-95.
PubMed
19) Ueki M, Yasunami Y, Ina K, et al. Diabetogenic effects of FK506 on renal subcapsular islet isografts in rat. Diabetes Res Clin Pract 1993 ; 20 (1) : 11-9.
PubMed
20) Hammond TG, Kind CN. Pancreatic and nephrotoxicity of immunomodulator compounds. Toxicol Lett 1995 ; 82-83 : 99-105.
 
21) Hernandez-Fisac I, Pizarro-Delgado J, Calle C, et al. Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets. Am J Transplant 2007 ; 7 (11) : 2455-62.
PubMed
22) Sanders CE Jr, Curtis JJ. Role of hypertension in chronic renal allograft dysfunction. Kidney Int Suppl 1995 ; 52 : S43-7.
PubMed
23) Cheigh JS, Haschemeyer RH, Wang JC, et al. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 1989 ; 2 (5 Pt 1) : 341-8.
 
24) Opelz G, Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005 ; 5 (11) : 2725-31.
PubMed
25) First MR, Neylan JF, Rocher LL, et al. Hypertension after renal transplantation. J Am Soc Nephrol 1994 ; 4 (8 Suppl) : S30-6.
 
26) Textor SC, Canzanello VJ, Taler SJ, et al. Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc 1994 ; 69 (12) : 1182-93.
PubMed
27) European best practice guidelines for renal transplantation. Section IV : Long-term management of the transplant recipient. IV. 5.2. Cardiovascular risks. Arterial hypertension. Nephrol Dial Transplant 2002 ; 17 Suppl 4 : 25-6.
 
28) K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004 ; 43 (5 Suppl 1) : S1-290.
 
29) Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management : a European Society of Hypertension Task Force document. J Hypertens 2009 ; 27 (11) : 2121-58.
PubMed
30) Sleight P, Redon J, Verdecchia P, et al. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens 2009 ; 27 (7) : 1360-9.
PubMed
31) Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010 ; 362 (17) : 1575-85.
PubMed
32) 日本腎臓学会 (編). エビデンスに基づくCKD診療ガイドライン 2013, 東京医学社, 東京, 2013.
 
33) Wheeler DC, Becker GJ. Summary of KDIGO guideline. What do we really know about man agement of blood pressure in patients with chronic kidney disease? Kidney Int 2013 ; 83 (3) : 377-83.
 
34) Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993 ; 91 (5) : 2144-9.
PubMed
35) Margreiter R. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation : a randomised multicentre study. Lancet 2002 ; 359 (9308) : 741-6.
PubMed
36) Kuypers DR, Neumayer HH, Fritsche L, et al. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients : a prospective randomized placebo-controlled 2-year study. Transplantation 2004 ; 78 (8) : 1204-11.
PubMed
37) Cross NB, Webster AC, Masson P, et al. Antihypertensive treatment for kidney transplant recipients. Cochrane Database Syst Rev 2009 (3) : CD003598.
PubMed
38) Curtis JJ, Luke RG, Jones P, et al. Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent. Am J Med 1988 ; 85 (2) : 134-8.
PubMed
39) Opelz G, Zeier M, Laux G, et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers : a collaborative transplant study report. J Am Soc Nephrol 2006 ; 17 (11) : 3257-62.
 
40) Heinze G, Mitterbauer C, Regele H, et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006 ; 17 (3) : 889-99.
PubMed
41) Ibrahim HN, Jackson S, Connaire J, et al. Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 2013 ; 24 (2) : 320-7.
PubMed
42) Holdaas H, Fellstrom B, Jardine AG, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients : a multicentre, randomised, placebo-controlled trial. Lancet 2003 ; 361 (9374) : 2024-31.
PubMed
43) Lentine KL, Brennan DC. Statin use after renal transplantation : a systematic quality review of trial-based evidence. Nephrol Dial Transplant 2004 ; 19 (9) : 2378-86.
 
44) Holdaas H, Fellstrom B, Cole E, et al. Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin : the ALERT extension study. Am J Transplant 2005 ; 5 (12) : 2929-36.
PubMed
45) Kasiske B, Cosio FG, Beto J, et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients : a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 2004 ; 4 Suppl 7 : 13-53.
 
46) Palmer SC, Navaneethan SD, Craig JC, et al. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev 2014 ; 1 : CD005019.
PubMed
47) Gonyea JE, Anderson CF. Weight change and serum lipoproteins in recipients of renal allografts. Mayo Clin Proc 1992 ; 67 (7) : 653-7.
PubMed
48) Moore R, Thomas D, Morgan E, et al. Abnormal lipid and lipoprotein profiles following renal transplantation. Transplant Proc 1993 ; 25 (1 Pt 2) : 1060-1.
 
49) Gaston RS, Kasiske BL, Fieberg AM, et al. Use of cardioprotective medications in kidney transplant recipients. Am J Transplant 2009 ; 9 (8) : 1811-5.
PubMed
50) 日本動脈硬化学会. 動脈硬化性疾患予防ガイドライン 2012年版, 杏林舎, 東京, 2012.
 
51) 平田睦子, 齋藤充生, 三宅真二, 他. シクロスポリンによるスタチン系薬剤の著しい血中濃度増加作用とその機序及び添付文書における情報の解析. 国立医薬品食品衛生研究所報告 2005 (123) : 37-40.
 
52) Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Pro tection) : a randomised placebo-controlled trial. Lancet 2011 ; 377 (9784) : 2181-92.
 
53) Ballantyne CM, Houri J, Notarbartolo A, et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia : a prospective, randomized, double-blind trial. Circulation 2003 ; 107 (19) : 2409-15.
 
54) Puthenparumpil JJ, Keough-Ryan T, Kiberd M, et al. Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population. Transplant Proc 2005 ; 37 (2) : 1033-5.
PubMed
55) Buchanan C, Smith L, Corbett J, et al. A retrospective analysis of ezetimibe treatment in renal transplant recipients. Am J Transplant 2006 ; 6 (4) : 770-4.
 
56) Kohnle M, Pietruck F, Kribben A, et al. Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation. Am J Transplant 2006 ; 6 (1) : 205-8.
PubMed
57) Summary of Recommendation Statements. Kidney Int Suppl (2011). 2013 ; 3 (3) : 263-65.
PubMed
58) Saito Y, Yokoyama M, Origasa H, et al. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors : sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008 ; 200 (1) : 135-40.
PubMed
59) Kono K, Fujii H, Nakai K, et al. Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. Kidney Int 2012 ; 82 (3) : 344-51.
PubMed
60) Hou W, Lv J, Perkovic V, et al. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease : a systematic review and meta-analysis. Eur Heart J 2013 ; 34 (24) : 1807-17.
 
61) Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004 ; 110 (2) : 227-39.
PubMed
62) Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease : the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013 ; 34 (38) : 2949-3003.
 
63) Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003 ; 108 (11) : 1404-18.
 
64) Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans : what is the warranty period of a normal scan? J Am Coll Cardiol 2003 ; 41 (8) : 1329-40.
PubMed
65) Carryer DJ, Askew JW, Hodge DO, et al. The timing and impact of follow-up studies after normal stress single-photon emission computed tomography sestamibi studies. Circ Cardiovasc Imaging 2010 ; 3 (5) : 520-6.
PubMed

18. 透析再導入時の注意点

P.146 掲載の参考文献
1) 日本移植学会. 臓器移植ファクトブック 2014. Available from : http://www.asas.or.jp/jst/pdf/factbook/factbook2014.pdf.
 
2) Kaplan B, Meier-Kriesche HU. Death after graft loss : an important late study endpoint in kidney transplantation. Am J Transplant 2002 ; 2 (10) : 970-4.
PubMed
3) Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003 ; 75 (8) : 1291-5.
 
4) Rao PS, Schaubel DE, Jia X, Li S, Port FK, Saran R. Survival on dialysis post-kidney transplant failure : results from the Scientific Registry of Transplant Recipients. Am J Kidney Dis 2007 ; 49 (2) : 294-300.
 
5) de Jonge H, Bammens B, Lemahieu W, Maes BD, Vanrenterghem Y. Comparison of peritoneal dialysis and haemodialysis after renal transplant failure. Nephrol Dial Transplant 2006 ; 21 (6) : 1669-74.
PubMed
6) Perl J, Hasan O, Bargman JM, Jiang D, Na Y, Gill JS, et al. Impact of dialysis modality on survival after kidney transplant failure. Clin J Am Soc Nephrol 2011 ; 6 (3) : 582-90.
PubMed
7) Goldfarb-Rumyantzev AS, Hurdle JF, Baird BC, Stoddard G, Wang Z, Scandling JD, et al. The role of pre-emptive re-transplant in graft and recipient outcome. Nephrol Dial Transplant 2006 ; 21 (5) : 1355-64.
PubMed
8) Gill JS, Abichandani R, Khan S, Kausz AT, Pereira BJ. Opportunities to improve the care of patients with kidney transplant failure. Kidney Int 2002 ; 61 (6) : 2193-200.
PubMed
9) Gregoor PJ, Kramer P, Weimar W, van Saase JL. Infections after renal allograft failure in patients with or without low-dose maintenance immunosuppression. Transplantation 1997 ; 63 (10) : 1528-30.
PubMed
10) Smak Gregoor PJ, Zietse R, van Saase JL, op de Hoek CT, JN IJ, Lavrijssen AT, et al. Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant 2001 ; 15 (6) : 397-401.
 
11) Kiberd BA, Belitsky P. The fate of the failed renal transplant. Transplantation 1995 ; 59 (4) : 645-7.
PubMed
12) Pham PT, Pham PC. Immunosuppressive management of dialysis patients with recently failed transplants. Semin Dial 2011 ; 24 (3) : 307-13.
PubMed
13) van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, et al. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer : population based retrospective cohort study. BMJ 2010 ; 340 : c570.
PubMed
14) Kendrick EA, Davis CL. Managing the failing allograft. Semin Dial 2005 ; 18 (6) : 529-39.
PubMed
15) Bennett WM. The failed renal transplant : in or out? Semin Dial 2005 ; 18 (3) : 188-9.
 
16) Vanrenterghem Y, Khamis S. The management of the failed renal allograft. Nephrol Dial Transplant 1996 ; 11 (6) : 955-7.
PubMed
17) Roberts CS, LaFond J, Fitts CT, Rajagopalan PR, Baliga P, Cofer JB, et al. New patterns of transplant nephrectomy in the cyclosporine era. J Am Coll Surg 1994 ; 178 (1) : 59-64.
PubMed
18) O'Sullivan DC, Murphy DM, McLean P, Donovan MG. Transplant nephrectomy over 20 years : factors involved in associated morbidity and mortality. J Urol 1994 ; 151 (4) : 855-8.
PubMed
19) Johnston O, Rose C, Landsberg D, Gourlay WA, Gill JS. Nephrectomy after transplant failure : current practice and outcomes. Am J Transplant 2007 ; 7 (8) : 1961-7.
PubMed
20) Ratcliffe PJ, Dudley CR, Higgins RM, Firth JD, Smith B, Morris PJ. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996 ; 348 (9028) : 643-8.
PubMed
21) Verresen L, Vanrenterghem Y, Waer M, Hauglustaine D, Michielsen P. Corticosteroid withdrawal syndrome in dialysis patients. Nephrol Dial Transplant 1988 ; 3 (4) : 476-7.
PubMed
22) Sever MS, Turkmen A, Yildiz A, Ecder T, Orhan Y. Fever in dialysis patients with recently rejected renal allografts. Int J Artif Organs 1998 ; 21 (7) : 403-7.
PubMed
23) Marrari M, Duquesnoy RJ. Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transpl Immunol 2010 ; 22 (3-4) : 105-9.
 
24) Del Bello A, Congy-Jolivet N, Sallusto F, Guilbeau-Frugier C, Cardeau-Desangles I, Fort M, et al. Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy. Clin J Am Soc Nephrol 2012 ; 7 (8) : 1310-9.
PubMed
25) USRDS annual report 2013. Available from : http://www.usrds.org/2013/pdf/v2_ch7_13.pdf.
 
26) 日本移植学会・日本臨床腎移植学会. 腎移植臨床登録集計報告 (2014) 2013年実施症例の集計報告と追跡調査結果. 移植 2014 ; 49 (2-3) : 240-60.
 

書評

最近チェックした商品履歴

Loading...